English | Español

Pharmaceuticals

+ Pharmaceuticals
Patient Daily | Mar 16, 2026

TRISH opens commercial spaceflight database to scientific community
+ Pharmaceuticals
Patient Daily | Mar 16, 2026

Ipsen withdraws Tazverik cancer drug after safety concerns in clinical trial
+ Pharmaceuticals
Patient Daily | Mar 16, 2026

FDA rejects Incyte’s lung cancer drug application due to issues at Catalent Indiana site
+ Pharmaceuticals
Patient Daily | Mar 16, 2026

AbbVie reports early trial results for weight loss drug ABBV-295
+ Pharmaceuticals
Patient Daily | Mar 16, 2026

Hansoh reports positive Phase 3 results for obesity drug olatorepatide in China
+ Pharmaceuticals
Patient Daily | Mar 16, 2026

FDA biologics director Vinay Prasad to depart in April, analysts predict impact on biotech
+ Pharmaceuticals
Patient Daily | Mar 16, 2026

Roche reports breast cancer drug giredestrant fails key Phase 3 trial
+ Pharmaceuticals
Patient Daily | Mar 16, 2026

Five therapies show progress in multiple myeloma treatment landscape

Trending
+ Pharmaceuticals
Patient Daily | Aug 4, 2026

Merck reports mixed results for tulisokibart in recent clinical trials and financial update
+ Pharmaceuticals
Patient Daily | Aug 6, 2026

FDA approves Replimune’s melanoma drug Tudriqev after advisory committee debate
+ Regulatory
M. R. Armstrong | Aug 4, 2026

Public Policy Solutions on 340B: 'The program has enriched big hospital execs'
+ Pharmaceuticals
Patient Daily | Aug 5, 2026

Bristol Myers Squibb and AstraZeneca reportedly in merger talks amid industry changes